Skip to main content

(Approval lapsed) Sultiame neuraxpharm 50mg film-coated tablets (Neuraxpharm)

Section 19A approved medicine
(Approval lapsed) Sultiame neuraxpharm 50mg film-coated tablets (Neuraxpharm)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
OSPOLOT sulthiame 50 mg tablet bottle - ARTG 18847
Indication(s)

Indicated as an anticonvulsant for behavioural disorders associated with epilepsy; hyperkinetic behaviour; temporal lobe epilepsy; myoclonic seizures; grand mal attacks; Jacksonian seizures.

Images
Picture of Sultiame neuraxpharm 50mg film-coated tablets (Neuraxpharm)

Help us improve the Therapeutic Goods Administration site